What’s New at DiaPharma?

Posted: March 3, 2021

It’s Not Just Support. It’s Solutions.


Immunoglobulin Testing Assays


 

Meet the Team

Diapharma

Tinu Adewole

East Territory Manager

Tinu has been with DiaPharma since July 2013. She enjoys staying healthy and active, these days by working with a virtual Personal Trainer, taking walks in the neighborhood, and doing online YouTube pilates & yoga videos. She says, “It took me about 3 months into the pandemic to get my act together. I didn’t want to put on any more ”Pandemic Pounds”!

She looks forward to traveling once things are safer and would love to go to Portugal. Home improvement projects give her a creative outlet, and she spends time binge watching Netflix as we all do!

Tinu has used this time to increase product knowledge and disease state knowledge through reading more publications, listening to webinars, and watching speakers during virtual conferences. Staying connected to customers via Zoom has been a good way to see each other “face to face”.

But there is no substitute for in person interaction and we all look forward to seeing our customers soon!!


Covid-19 ADAMTS-13

Clot Club

Insights into an Imbalanced vWF Antigen to ADAMTS13 Activity Ratio in COVID-19.

Contributed by Abi Kasberg, Ph.D.

One of the many complicated outcomes associated with severe cases of COVID-19 is the high occurrence of thrombotic and microthrombotic events. SARS-CoV-2-induced endothelial injury drives elevated inflammatory responses that promote dysregulated coagulation systems, in a condition named COVID-19-associated coagulopathy (CAC). The severity of CAC is associated with the onset of thromboembolisms and thrombotic microangiopathies (TMAs). Additional clinical findings have highlighted the occurrences of microvascular thrombi and hypercoagulability in COVID-19 patients. This suggests that vascular endothelia and microvasculature may be experiencing dysregulated hemostasis following SARS-CoV-2 infection. Given the recent emergence and worldwide impact of COVID-19, it is of great importance to identify and understand the mechanisms that are driving microthrombotic complications in COVID-19 patients.

Continue Reading


TMA ADAMTS-13


Visit diapharma.com for ADAMTS13, vWF, Thrombin Generation Assays, and more.

Explore assays from DiaPharma to answer your COVID-19 research questions.


It’s Not Just Support. It’s Solutions.

Our scientific experts and customer support teams are just a call or click away.

diapharma


diapharma hemostasis assays


Copyright © 2021 DiaPharma Group, Inc. All rights reserved.

DiaPharma Group, Inc. 8948 Beckett Rd 45069 West Chester US

ML-00-00767Rev01